Dexamethasone treatment of murine auditory hair cells and cochlear explants attenuates tumor necrosis factor-α-initiated apoptotic damage

PLoS One. 2023 Sep 21;18(9):e0291780. doi: 10.1371/journal.pone.0291780. eCollection 2023.

Abstract

The most common cause of sensorineural hearing loss is damage of auditory hair cells. Tumor necrosis factor-alpha (TNF-α) is closely associated with sensorineural hearing loss. The present study examined the preconditioning effect of dexamethasone (DEX) on TNF-α-induced ototoxicity in mouse auditory hair cells (HEI-OC1) and cochlear explants. Treatment of HEI-OC1 with 10 ng/ml TNF-α for 24 h decreased cell viability, increased the accumulation of reactive oxygen species (ROS), and induced caspase-mediated apoptotic signaling pathways. Pretreatment with 10 nM DEX for 6 h before TNF-α exposure restored cell viability, decreased ROS accumulation, and attenuated apoptotic signaling activation induced by TNF-α. Incubation of cochlear explants with 20 ng/ml TNF-α for 24 h resulted in significant loss of both inner hair cells (IHCs) and outer hair cells (OHCs) and an increase in apoptotic activation accessed by annexin V staining. The cochlear explants pre-incubated with 10 nM DEX attenuated TNF-α ototoxicity in both IHCs and OHCs and apoptotic cell death. These results indicated that DEX plays a protective role in ototoxicity induced by TNF-α through attenuation of caspase-dependent apoptosis signaling pathway and ROS accumulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dexamethasone / pharmacology
  • Hair Cells, Auditory, Outer
  • Hearing Loss, Sensorineural*
  • Mice
  • Ototoxicity*
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor-alpha
  • Reactive Oxygen Species
  • Dexamethasone

Grants and funding

This study was supported by a grant from the National Research Foundation of Korea (NRF), funded by the government of South Korea (MSIT) [grant number 2021R1A2C1012624, JW Chung] and the Ulsan University Hospital Research Grant (UUH-2021-04, BC Kang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript